




Searching News Database: placenta
HSMN NewsFeed - 17 Nov 2020
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
Celularity Announces Appointments of Chief Medical Officer and Senior Vice President of Regulatory Affairs
HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
HSMN NewsFeed - 9 Aug 2018
MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
MiMedx Receives Regulatory Approval to Commercialize Product Portfolio in Australia
HSMN NewsFeed - 17 Nov 2017
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
MiMedx Market Leadership Well Positioned In Light Of FDA New Guidance Document
HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
HSMN NewsFeed - 25 Jul 2016
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
MiMedx Announces Nationwide Launch of New Ambient Temperature Version of OrthoFlo
HSMN NewsFeed - 17 May 2016
MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
HSMN NewsFeed - 12 Aug 2015
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
Japan Grants Safety Clearance to Pluristem's PLX-PAD Cells for Use in Clinical Trials
HSMN NewsFeed - 15 Jul 2015
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
Fate Therapeutics Appoints Dr. Stewart Abbot as Vice President, Translational Research
HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
HSMN NewsFeed - 9 Jun 2014
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
HSMN NewsFeed - 4 Mar 2014
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
HSMN NewsFeed - 5 Feb 2014
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
Pluristem Strengthens Executive Team; Announces Senior Executive Appointments
HSMN NewsFeed - 21 Jan 2014
Pluristem's Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints
Pluristem's Phase I/II Muscle Injury Trial Successfully Meets Primary Safety & Efficacy Endpoints
HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
HSMN NewsFeed - 18 Apr 2013
Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine
Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine
HSMN NewsFeed - 4 Jan 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
HSMN NewsFeed - 5 Sep 2012
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
Third Critically Ill Patient Successfully Treated With Pluristem's PLX Cells Under Compassionate Use
HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
HSMN NewsFeed - 18 Apr 2011
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
HSMN NewsFeed - 8 Apr 2011
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
HSMN NewsFeed - 27 Oct 2010
PerkinElmer Releases DELFIA(R) Xpress PlGF Assay for Early Detection of Pre-eclampsia in Pregnant Women
PerkinElmer Releases DELFIA(R) Xpress PlGF Assay for Early Detection of Pre-eclampsia in Pregnant Women
HSMN NewsFeed - 16 Jun 2009
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
Pluristem Therapeutics Receives European Regulatory Approval for Placental-Derived Stem Cell Clinical Trial
HSMN NewsFeed - 30 Apr 2009
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
HSMN NewsFeed - 6 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 4 Nov 2008
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
FDA Approves Additional Indication for Norditropin(R) for Small for Gestational Age (SGA) in Children
HSMN NewsFeed - 8 Jan 2008
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
Pluristem Announces Second Clinical Indication Revascularization Effect After PLX-PAD Therapy
HSMN NewsFeed - 27 Dec 2007
Sequenom Announces New York State Approval of a Noninvasive Prenatal Test
Sequenom Announces New York State Approval of a Noninvasive Prenatal Test
HSMN NewsFeed - 1 Oct 2007
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell
PerkinElmer to Expand Genetic Screening Business Through Acquisition of ViaCell
HSMN NewsFeed - 23 Aug 2007
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
Phase 3 Oncology Program for Aflibercept (VEGF Trap) Initiated by Regeneron and sanofi-aventis
HSMN NewsFeed - 27 Jun 2007
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
Beckman Coulter Grants Sublicense to Dade Behring for Novel Cardiac Markers
HSMN NewsFeed - 16 Jan 2007
Pluristem Appoints Dr. William R. Prather as Senior VP of Corporate Development
Pluristem Appoints Dr. William R. Prather as Senior VP of Corporate Development
HSMN NewsFeed - 4 Jan 2007
Medistem Laboratories Appoints Thomas Ichim to Be Chief of Scientific Development
Medistem Laboratories Appoints Thomas Ichim to Be Chief of Scientific Development
HSMN NewsFeed - 20 Dec 2006
Regeneron Reports Blocking New Angiogenesis Target May Offer Novel Approach to Slowing Tumor Growth
Regeneron Reports Blocking New Angiogenesis Target May Offer Novel Approach to Slowing Tumor Growth
HSMN NewsFeed - 26 Oct 2006
NeoStem, Inc. Appoints Julio C. Guerra, MD, ABP, as Director of Sales and Marketing
NeoStem, Inc. Appoints Julio C. Guerra, MD, ABP, as Director of Sales and Marketing
HSMN NewsFeed - 18 Oct 2006
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
Bayer HealthCare and Regeneron to Collaborate on VEGF Trap for the Treatment of Eye Diseases
HSMN NewsFeed - 6 Mar 2006
Pluristem Strengthens Business Strategy, Company to Focus on Commercializing Cell Therapy Products
Pluristem Strengthens Business Strategy, Company to Focus on Commercializing Cell Therapy Products
Additional items found! 28

Members Archive contains
28 additional stories matching:
placenta
(Password required)
placenta
(Password required)